Clinical Trial: Phase I Study Multi Dose of 7.5mg Tolvaptan in Health Male

U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07166887) titled 'Phase I Study Multi Dose of 7.5mg Tolvaptan in Health Male' on Aug. 22.

Brief Summary: pharmacokinetics, pharmacological effects and safety of multi dose of 7.5mg Tolvaptan tablet in healthy male subjects

Study Start Date: June 07, 2011

Study Type: INTERVENTIONAL

Condition: Healthy Subjects

Intervention: DRUG: Tolvaptan

One dose on the first day and one dose on days 3-9, for a total of eight doses.

Recruitment Status: COMPLETED

Sponsor: Otsuka Beijing Research Institute

Disclaimer: Curated by HT Syndication....